Product Program year 2025 Source: CMS Open Payments

Guidezilla

Device Guidezilla_IC

PDI 08714729839859

Open in the dashboard

General payments

$10,654

452 payments

Research payments

$0

0 payments

Through program year 2025, $10,654 in general payments and $0 in research payments were reported against Guidezilla (Guidezilla_IC).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $1,395 60
2024 General $1,391 80
2023 General $2,417 121
2022 General $5,452 191

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $10,654 452 payments
Top recipients General payments · program year 2025
  1. Rakesh Sahni Cardiovascular Disease · Clark, NJ $184 13% · 5 payments
  2. Craig Snyder Interventional Cardiology · Edison, NJ $169 12% · 2 payments
  3. Howard Noveck Interventional Cardiology · Edison, NJ $118 8% · 3 payments
  4. Rakesh Passi Cardiovascular Disease · East Brunswick, NJ $113 8% · 2 payments
  5. Raj Ballal Cardiovascular Disease · Edison, NJ $111 8% · 3 payments

The top 5 of 41 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Cardiovascular Disease Internal Medicine $741 53% · 14 practitioners
  2. Interventional Cardiology Internal Medicine $571 41% · 17 practitioners
  3. Physician Assistant, Medical Physician Assistant $18 1% · 1 practitioner
  4. Nurse Practitioner, Acute Care Nurse Practitioner $14 <1% · 1 practitioner
  5. Emergency Medicine $14 <1% · 1 practitioner

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New Jersey $1,064 76% · 13 recipients
  2. New York $108 8% · 4 recipients
  3. California $55 4% · 4 recipients
  4. Washington $33 2% · 1 recipient
  5. Nevada $25 2% · 6 recipients

The top 5 of 13 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

452 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record